Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

262
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
262
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.7K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.7K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

204
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
204
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

203
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
203
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

212
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
212
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

291
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
291

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The use of cultured human hepatocytes as a test system to evaluate cell proliferation as a key event in nongenotoxic carcinogenesis.

Archives of toxicology·2026
Same author

Nitroparaffin transcriptional profiles and toxicokinetics support chemical-specific carcinogenicity assessment.

Regulatory toxicology and pharmacology : RTP·2026
Same author

Response to the Letter from Professor C. R. Wolf and colleagues concerning CRT, 55: 549-586, 2025: The modes of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR) and the peroxisome-proliferator-activated receptor alpha (PPARα) are not relevant to human cancer risk: an updated critical evaluation.

Critical reviews in toxicology·2026
Same author

Utilizing Physiologically Based Pharmacokinetic Modeling and Virtual Simulation for Simvastatin Tablets to Evaluate the Sensitivity of Using Parent vs Metabolite as Analyte on Bioequivalence Assessment.

The AAPS journal·2025
Same author

Model-based dose selection and pharmacokinetic bridging of subcutaneous from intravenous pembrolizumab across indications.

European journal of cancer (Oxford, England : 1990)·2025
Same author

Estimating safe doses of perfluorooctane sulfonate (PFOS): an international collaboration.

Archives of toxicology·2025

Related Experiment Video

Updated: Dec 21, 2025

Topical Application Bioassay to Quantify Insecticide Toxicity for Mosquitoes and Fruit Flies
09:37

Topical Application Bioassay to Quantify Insecticide Toxicity for Mosquitoes and Fruit Flies

Published on: January 19, 2022

6.8K

Physiologically Based Pharmacokinetic Modeling in Risk Assessment: Case Study With Pyrethroids.

Pankajini Mallick1, Gina Song1, Alina Y Efremenko1

  • 1ScitoVation, LLC, Durham, North Carolina 27713.

Toxicological Sciences : an Official Journal of the Society of Toxicology
|May 19, 2020
PubMed
Summary
This summary is machine-generated.

Children show lower or equal internal exposure to pyrethroid insecticides than adults. Physiologically based pharmacokinetic (PBPK) modeling confirms no additional safety factor is needed for age-related differences in risk assessment.

Keywords:
IVIVEPBPK modelingpyrethroidsrisk assessment

More Related Videos

Vegetated Treatment Systems for Removing Contaminants Associated with Surface Water Toxicity in Agriculture and Urban Runoff
08:49

Vegetated Treatment Systems for Removing Contaminants Associated with Surface Water Toxicity in Agriculture and Urban Runoff

Published on: May 15, 2017

11.0K
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.5K

Related Experiment Videos

Last Updated: Dec 21, 2025

Topical Application Bioassay to Quantify Insecticide Toxicity for Mosquitoes and Fruit Flies
09:37

Topical Application Bioassay to Quantify Insecticide Toxicity for Mosquitoes and Fruit Flies

Published on: January 19, 2022

6.8K
Vegetated Treatment Systems for Removing Contaminants Associated with Surface Water Toxicity in Agriculture and Urban Runoff
08:49

Vegetated Treatment Systems for Removing Contaminants Associated with Surface Water Toxicity in Agriculture and Urban Runoff

Published on: May 15, 2017

11.0K
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.5K

Area of Science:

  • Environmental Health
  • Toxicology
  • Pharmacokinetics

Background:

  • Assessing risks to sensitive populations is crucial in risk assessment.
  • Age-related sensitivity to pyrethroid insecticides is a key concern.

Purpose of the Study:

  • To predict age-dependent changes in target tissue exposure to eight pyrethroids.
  • To calculate a Data-derived Extrapolation Factor (DDEF) for age-related pharmacokinetic differences in humans.

Main Methods:

  • Developed a generic human physiologically based pharmacokinetic (PBPK) model for pyrethroids.
  • Utilized in vitro to in vivo extrapolation and life-stage modeling.
  • Modeled exposure to eight different pyrethroids.

Main Results:

  • Age-related differences in brain exposure to pyrethroids are primarily due to metabolic capacity and physiological variations between children and adults.
  • Internal pyrethroid concentrations in children are equal to or lower than in adults for identical external exposures.
  • Data-derived Extrapolation Factor (DDEF) values were close to 1 for all eight pyrethroids.

Conclusions:

  • No additional adjustment factor is required for age-related pharmacokinetic differences in pyrethroid risk assessment.
  • The study provides a robust framework for evaluating age-specific pesticide exposure.
  • Findings support current risk assessment protocols for pyrethroids regarding pediatric populations.